# EDGAR Filing Document

**Accession Number:** 0001415995
**File Stem:** 0001999371-26-013186
**Filing Date:** 2026-6
**Character Count:** 4645
**Document Hash:** 27d212590f233e175a782e4338e70a21
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001999371-26-013186.hdr.sgml**: 20260622

**ACCESSION NUMBER**: 0001999371-26-013186

**CONFORMED SUBMISSION TYPE**: 497

**PUBLIC DOCUMENT COUNT**: 14

**FILED AS OF DATE**: 20260622

**DATE AS OF CHANGE**: 20260622

**EFFECTIVENESS DATE**: 20260622

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** New York Life Investments ETF Trust
- **CENTRAL INDEX KEY:** 0001415995

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** 497
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-152915
- **FILM NUMBER:** 261105599

**BUSINESS ADDRESS:**
- **STREET 1:** 51 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10010
- **BUSINESS PHONE:** (212) 576-5018

**MAIL ADDRESS:**
- **STREET 1:** 51 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10010

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IndexIQ ETF Trust
- **DATE OF NAME CHANGE:** 20080908

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IQSHARES Trust
- **DATE OF NAME CHANGE:** 20080808

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IQSHARES Trust 1
- **DATE OF NAME CHANGE:** 20071024

## Series and Classes Contracts Data

### NYLI Global Equity R&D Leaders ETF (Series ID: S000074744)

---

|  |  |  |
|:---|:---|:---|
| Class Name                         | Ticker Symbol | Class ID   |
| NYLI Global Equity R&D Leaders ETF | WRND          | C000232897 |

---

### NYLI U.S. Large Cap R&D Leaders ETF (Series ID: S000074745)

---

|  |  |  |
|:---|:---|:---|
| Class Name                          | Ticker Symbol | Class ID   |
| NYLI U.S. Large Cap R&D Leaders ETF | LRND          | C000232898 |

---

## Series and Classes Contracts Data

### NYLI Global Equity R&D Leaders ETF (Series ID: S000074744)

| Class ID   | Class Name                         | Ticker Symbol   |
|:---|:---|:---|
| C000232897 | NYLI Global Equity R&D Leaders ETF | WRND            |

### NYLI U.S. Large Cap R&D Leaders ETF (Series ID: S000074745)

| Class ID   | Class Name                          | Ticker Symbol   |
|:---|:---|:---|
| C000232898 | NYLI U.S. Large Cap R&D Leaders ETF | LRND            |

?xml version='1.0' encoding='ASCII'? rdleaders-497_062226

**New York Life Investments ETF Trust**

**NYLI U.S. Large Cap R&D Leaders ETF NYLI Global Equity R&D Leaders ETF (** **the** **"** **Fund** **")**

Supplement dated June 22, 2026 ("Supplement") to each Fund's Prospectus

and Summary Prospectus, as supplemented

**Important Notice Regarding Change in Investment Policy**

*Capitalized terms and certain other terms used in this Supplement, unless otherwise defined in this Supplement, have the meanings assigned to them in the Summary Prospectus and Prospectus.*

The Board of Trustees of the New York Life Investments ETF Trust approved changes to the non-fundamental investment policy adopted pursuant to Rule 35d-1 under the Investment Company Act of 1940 for each of the following Funds, which is expected to go into effect on August 28, 2026:

**NYLI U.S. Large Cap R&D Leaders ETF**

The Fund's policy to invest, under normal circumstances, at least 80% of the value of its assets (net assets plus the amount of any borrowings for investment purposes) in securities of U.S. large-capitalization issuers, will be revised as follows:

The Fund will, under normal circumstances, invest at least 80% of its assets (net assets plus the amount of any borrowings for investment purposes) in securities of U.S. large-capitalization issuers determined to be R&D Leaders.

For purposes of compliance with the Fund's policy, large-capitalization issuers are issuers whose market capitalization is within the range of market capitalizations of issuers included in the NYLIM U.S. Large Cap R&D Leaders Index. An issuer is determined to be an R&D Leader if it is included in the NYLIM U.S. Large Cap R&D Leaders Index.

**NYLI Global Equity R&D Leaders ETF**

The Fund's policy to invest, under normal circumstances, at least 80% of the value of its assets (net assets plus the amount of any borrowings for investment purposes) in equity securities, will be revised as follows:

The Fund will, under normal circumstances, invest at least 80% of its assets (net assets plus the amount of any borrowings for investment purposes) in equity securities determined to be R&D Leaders.

For purposes of compliance with the Fund's policy, an issuer is determined to be an R&D Leader if it is included in the NYLIM Global Equity R&D Leaders Index.

**Investors Should Retain This Supplement For Future** **Reference**

REG-00135-06/26